 Kalie Tommerdahl
Concepts (105)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetic Nephropathies | 9 | 2023 | 234 | 3.700 |
Why?
| | Diabetes Mellitus, Type 2 | 9 | 2024 | 2094 | 2.350 |
Why?
| | Metformin | 2 | 2023 | 276 | 1.240 |
Why?
| | Diabetes Mellitus, Type 1 | 10 | 2024 | 3244 | 1.180 |
Why?
| | Cystic Fibrosis | 2 | 2020 | 955 | 0.720 |
Why?
| | Fructosamine | 1 | 2019 | 14 | 0.670 |
Why?
| | Deoxyglucose | 1 | 2019 | 43 | 0.670 |
Why?
| | Glucose Tolerance Test | 1 | 2020 | 343 | 0.650 |
Why?
| | Serum Albumin | 1 | 2019 | 137 | 0.630 |
Why?
| | Insulin Resistance | 2 | 2024 | 1072 | 0.600 |
Why?
| | Kidney | 6 | 2024 | 1187 | 0.560 |
Why?
| | Prediabetic State | 1 | 2019 | 219 | 0.550 |
Why?
| | Adolescent | 12 | 2024 | 17830 | 0.450 |
Why?
| | Diabetes Mellitus | 1 | 2020 | 900 | 0.410 |
Why?
| | Hypoglycemic Agents | 4 | 2022 | 1008 | 0.380 |
Why?
| | Glucagon-Like Peptide-1 Receptor | 2 | 2022 | 71 | 0.370 |
Why?
| | Humans | 21 | 2024 | 114616 | 0.270 |
Why?
| | Creatinine | 3 | 2022 | 425 | 0.250 |
Why?
| | Glomerular Filtration Rate | 3 | 2024 | 604 | 0.230 |
Why?
| | Hyperoxia | 1 | 2024 | 99 | 0.210 |
Why?
| | Receptors, Prolactin | 2 | 2012 | 8 | 0.200 |
Why?
| | Glucosides | 1 | 2022 | 36 | 0.200 |
Why?
| | Cardiovascular Diseases | 2 | 2024 | 1727 | 0.200 |
Why?
| | Benzhydryl Compounds | 1 | 2022 | 60 | 0.190 |
Why?
| | Glucagon-Like Peptide 1 | 1 | 2022 | 101 | 0.190 |
Why?
| | Child | 5 | 2023 | 18402 | 0.180 |
Why?
| | Diabetic Neuropathies | 1 | 2021 | 79 | 0.180 |
Why?
| | Transcriptional Activation | 2 | 2012 | 337 | 0.170 |
Why?
| | Pulse Wave Analysis | 1 | 2021 | 207 | 0.170 |
Why?
| | Albuminuria | 1 | 2020 | 164 | 0.170 |
Why?
| | Diabetic Ketoacidosis | 1 | 2022 | 159 | 0.170 |
Why?
| | Oxygen | 2 | 2024 | 854 | 0.170 |
Why?
| | Diabetic Retinopathy | 1 | 2021 | 149 | 0.160 |
Why?
| | Glycation End Products, Advanced | 1 | 2019 | 57 | 0.160 |
Why?
| | Respiratory Function Tests | 1 | 2020 | 522 | 0.160 |
Why?
| | Risk Factors | 2 | 2021 | 8628 | 0.150 |
Why?
| | Clinical Trials as Topic | 1 | 2022 | 931 | 0.150 |
Why?
| | Phenotype | 2 | 2022 | 2796 | 0.130 |
Why?
| | Hypoxia | 1 | 2020 | 956 | 0.110 |
Why?
| | Hemodynamics | 3 | 2024 | 1012 | 0.110 |
Why?
| | Mass Screening | 1 | 2019 | 1004 | 0.100 |
Why?
| | Chitinase-3-Like Protein 1 | 2 | 2022 | 17 | 0.100 |
Why?
| | Male | 7 | 2024 | 55549 | 0.100 |
Why?
| | Female | 8 | 2024 | 59461 | 0.100 |
Why?
| | HMGN2 Protein | 1 | 2011 | 3 | 0.100 |
Why?
| | Estrogen Receptor alpha | 1 | 2012 | 121 | 0.100 |
Why?
| | STAT5 Transcription Factor | 1 | 2011 | 44 | 0.090 |
Why?
| | Receptors, Progesterone | 1 | 2012 | 319 | 0.090 |
Why?
| | Tumor Suppressor Proteins | 1 | 2011 | 282 | 0.080 |
Why?
| | Insulin | 3 | 2024 | 2076 | 0.080 |
Why?
| | Cell Nucleus | 1 | 2011 | 554 | 0.080 |
Why?
| | Obesity | 1 | 2021 | 2507 | 0.080 |
Why?
| | Transcription, Genetic | 1 | 2011 | 1313 | 0.060 |
Why?
| | Young Adult | 3 | 2024 | 10455 | 0.050 |
Why?
| | Biomarkers | 2 | 2024 | 3405 | 0.050 |
Why?
| | Threonine | 1 | 2022 | 40 | 0.050 |
Why?
| | Histidine | 1 | 2022 | 57 | 0.050 |
Why?
| | Lipocalin-2 | 1 | 2022 | 61 | 0.050 |
Why?
| | Lipoproteins | 1 | 2022 | 159 | 0.050 |
Why?
| | Chemokine CCL2 | 1 | 2022 | 105 | 0.050 |
Why?
| | Albumins | 1 | 2022 | 89 | 0.050 |
Why?
| | Leucine | 1 | 2022 | 102 | 0.050 |
Why?
| | Breast Neoplasms | 1 | 2012 | 1862 | 0.050 |
Why?
| | Tryptophan | 1 | 2022 | 135 | 0.050 |
Why?
| | p-Aminohippuric Acid | 1 | 2020 | 6 | 0.050 |
Why?
| | Triglycerides | 1 | 2022 | 467 | 0.040 |
Why?
| | Iohexol | 1 | 2020 | 16 | 0.040 |
Why?
| | Furosemide | 1 | 2020 | 32 | 0.040 |
Why?
| | Interleukin-18 | 1 | 2022 | 219 | 0.040 |
Why?
| | Cell Transformation, Neoplastic | 2 | 2012 | 308 | 0.040 |
Why?
| | Glucose Clamp Technique | 1 | 2020 | 181 | 0.040 |
Why?
| | Insulin Infusion Systems | 1 | 2022 | 297 | 0.040 |
Why?
| | Amino Acids | 1 | 2022 | 448 | 0.040 |
Why?
| | Blood Glucose Self-Monitoring | 1 | 2022 | 498 | 0.040 |
Why?
| | Diabetes Complications | 1 | 2020 | 211 | 0.040 |
Why?
| | Precision Medicine | 1 | 2020 | 336 | 0.040 |
Why?
| | Gene Expression Regulation, Neoplastic | 2 | 2012 | 1141 | 0.030 |
Why?
| | Body Composition | 1 | 2020 | 590 | 0.030 |
Why?
| | Sex Characteristics | 1 | 2020 | 640 | 0.030 |
Why?
| | Disease Management | 1 | 2020 | 560 | 0.030 |
Why?
| | Adiposity | 1 | 2020 | 457 | 0.030 |
Why?
| | Blood Glucose | 1 | 2022 | 1819 | 0.030 |
Why?
| | Genes, Neoplasm | 1 | 2012 | 20 | 0.030 |
Why?
| | Tissue Array Analysis | 1 | 2012 | 48 | 0.030 |
Why?
| | Prolactin | 1 | 2012 | 96 | 0.030 |
Why?
| | Tumor Cells, Cultured | 1 | 2012 | 849 | 0.020 |
Why?
| | Gene Knockdown Techniques | 1 | 2011 | 299 | 0.020 |
Why?
| | Down-Regulation | 1 | 2012 | 594 | 0.020 |
Why?
| | Protein Transport | 1 | 2011 | 395 | 0.020 |
Why?
| | Neoplasm Proteins | 1 | 2012 | 384 | 0.020 |
Why?
| | Up-Regulation | 1 | 2012 | 807 | 0.020 |
Why?
| | Protein Structure, Tertiary | 1 | 2011 | 796 | 0.020 |
Why?
| | Phosphorylation | 1 | 2012 | 1569 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2011 | 1982 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2011 | 1131 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2011 | 2785 | 0.020 |
Why?
| | Biomarkers, Tumor | 1 | 2012 | 1040 | 0.020 |
Why?
| | Protein Binding | 1 | 2011 | 1888 | 0.020 |
Why?
| | Disease Progression | 1 | 2012 | 2380 | 0.020 |
Why?
| | Prognosis | 1 | 2012 | 3328 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2011 | 2710 | 0.010 |
Why?
| | Models, Biological | 1 | 2011 | 1620 | 0.010 |
Why?
| | Adult | 1 | 2024 | 30528 | 0.010 |
Why?
| | Mutation | 1 | 2012 | 3344 | 0.010 |
Why?
| | Animals | 1 | 2020 | 31692 | 0.010 |
Why?
|
|
Tommerdahl's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|